Literature DB >> 26588927

Scripts for TRUMP data analyses. Part II (HLA-related data): statistical analyses specific for hematopoietic stem cell transplantation.

Junya Kanda1.   

Abstract

The Transplant Registry Unified Management Program (TRUMP) made it possible for members of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) to analyze large sets of national registry data on autologous and allogeneic hematopoietic stem cell transplantation. However, as the processes used to collect transplantation information are complex and differed over time, the background of these processes should be understood when using TRUMP data. Previously, information on the HLA locus of patients and donors had been collected using a questionnaire-based free-description method, resulting in some input errors. To correct minor but significant errors and provide accurate HLA matching data, the use of a Stata or EZR/R script offered by the JSHCT is strongly recommended when analyzing HLA data in the TRUMP dataset. The HLA mismatch direction, mismatch counting method, and different impacts of HLA mismatches by stem cell source are other important factors in the analysis of HLA data. Additionally, researchers should understand the statistical analyses specific for hematopoietic stem cell transplantation, such as competing risk, landmark analysis, and time-dependent analysis, to correctly analyze transplant data. The data center of the JSHCT can be contacted if statistical assistance is required.

Entities:  

Keywords:  Competing risk; HLA mismatch; Landmark analysis; Mismatch direction; Time-dependent analysis

Mesh:

Substances:

Year:  2015        PMID: 26588927     DOI: 10.1007/s12185-015-1907-9

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  21 in total

Review 1.  Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

Authors:  T A Gooley; W Leisenring; J Crowley; B E Storer
Journal:  Stat Med       Date:  1999-03-30       Impact factor: 2.373

Review 2.  Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling.

Authors:  J P Klein; J D Rizzo; M J Zhang; N Keiding
Journal:  Bone Marrow Transplant       Date:  2001-12       Impact factor: 5.483

Review 3.  Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis.

Authors:  J P Klein; J D Rizzo; M J Zhang; N Keiding
Journal:  Bone Marrow Transplant       Date:  2001-11       Impact factor: 5.483

Review 4.  Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation.

Authors:  Simona Iacobelli
Journal:  Bone Marrow Transplant       Date:  2013-03       Impact factor: 5.483

Review 5.  The role of HLA antibodies in allogeneic SCT: is the 'type-and-screen' strategy necessary not only for blood type but also for HLA?

Authors:  S Yoshihara; K Taniguchi; H Ogawa; H Saji
Journal:  Bone Marrow Transplant       Date:  2012-01-09       Impact factor: 5.483

6.  Impact of HLA mismatch direction on the outcome of unrelated bone marrow transplantation: a retrospective analysis from the Japan Society for Hematopoietic Cell Transplantation.

Authors:  Junya Kanda; Tatsuo Ichinohe; Shigeo Fuji; Yoshinobu Maeda; Kazuteru Ohashi; Takahiro Fukuda; Koichi Miyamura; Koji Iwato; Tetsuya Eto; Hirohisa Nakamae; Naoki Kobayashi; Takehiko Mori; Shin-Ichiro Mori; Yasuo Morishima; Yoshiko Atsuta; Yoshinobu Kanda
Journal:  Biol Blood Marrow Transplant       Date:  2014-10-18       Impact factor: 5.742

7.  Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991-2000).

Authors:  Yoshinobu Kanda; Shigeru Chiba; Hisamaru Hirai; Hisashi Sakamaki; Tohru Iseki; Yoshihisa Kodera; Takahiro Karasuno; Shinichiro Okamoto; Noriyuki Hirabayashi; Koji Iwato; Atsuo Maruta; Yoshihiro Fujimori; Tatsuo Furukawa; Shin Mineishi; Keitaro Matsuo; Nobuyuki Hamajima; Masahiro Imamura
Journal:  Blood       Date:  2003-04-24       Impact factor: 22.113

8.  Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome.

Authors:  Neal Flomenberg; Lee Ann Baxter-Lowe; Dennis Confer; Marcelo Fernandez-Vina; Alexandra Filipovich; Mary Horowitz; Carolyn Hurley; Craig Kollman; Claudio Anasetti; Harriet Noreen; Ann Begovich; William Hildebrand; Effie Petersdorf; Barbara Schmeckpeper; Michelle Setterholm; Elizabeth Trachtenberg; Thomas Williams; Edmond Yunis; Daniel Weisdorf
Journal:  Blood       Date:  2004-06-10       Impact factor: 22.113

9.  High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.

Authors:  Stephanie J Lee; John Klein; Michael Haagenson; Lee Ann Baxter-Lowe; Dennis L Confer; Mary Eapen; Marcelo Fernandez-Vina; Neal Flomenberg; Mary Horowitz; Carolyn K Hurley; Harriet Noreen; Machteld Oudshoorn; Effie Petersdorf; Michelle Setterholm; Stephen Spellman; Daniel Weisdorf; Thomas M Williams; Claudio Anasetti
Journal:  Blood       Date:  2007-09-04       Impact factor: 22.113

10.  High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism.

Authors:  Takakazu Kawase; Yasuo Morishima; Keitaro Matsuo; Koichi Kashiwase; Hidetoshi Inoko; Hiroh Saji; Shunichi Kato; Takeo Juji; Yoshihisa Kodera; Takehiko Sasazuki
Journal:  Blood       Date:  2007-06-06       Impact factor: 22.113

View more
  26 in total

1.  Impact of the presence of HLA 1-locus mismatch and the use of low-dose antithymocyte globulin in unrelated bone marrow transplantation.

Authors:  K Kawamura; J Kanda; S Fuji; M Murata; K Ikegame; K Yoshioka; T Fukuda; Y Ozawa; N Uchida; K Iwato; T Sakura; M Hidaka; H Hashimoto; T Ichinohe; Y Atsuta; Y Kanda
Journal:  Bone Marrow Transplant       Date:  2017-07-17       Impact factor: 5.483

2.  Severe acute graft-versus-host disease increases the incidence of blood stream infection and mortality after allogeneic hematopoietic cell transplantation: Japanese transplant registry study.

Authors:  Yoshitaka Inoue; Keiji Okinaka; Shigeo Fuji; Yoshihiro Inamoto; Naoyuki Uchida; Takashi Toya; Kazuhiro Ikegame; Tetsuya Eto; Yukiyasu Ozawa; Koji Iwato; Yoshinobu Kanda; Yoshiko Atsuta; Masao Ogata; Takahiro Fukuda
Journal:  Bone Marrow Transplant       Date:  2021-04-19       Impact factor: 5.483

3.  Effect of graft-versus-host disease on outcomes after pediatric single cord blood transplantation.

Authors:  Junya Kanda; Katsutsugu Umeda; Koji Kato; Makoto Murata; Junichi Sugita; Souichi Adachi; Katsuyoshi Koh; Maiko Noguchi; Hiroaki Goto; Nao Yoshida; Maho Sato; Yuhki Koga; Tsukasa Hori; Yuko Cho; Atsushi Ogawa; Masami Inoue; Yoshiko Hashii; Yoshiko Atsuta; Takanori Teshima
Journal:  Bone Marrow Transplant       Date:  2020-03-11       Impact factor: 5.483

4.  BM is preferred over PBSCs in transplantation from an HLA-matched related female donor to a male recipient.

Authors:  Hideki Nakasone; Koji Kawamura; Kimikazu Yakushijin; Akihito Shinohara; Masatsugu Tanaka; Kazuteru Ohashi; Shuichi Ota; Naoyuki Uchida; Takahiro Fukuda; Hirohisa Nakamae; Ken-Ichi Matsuoka; Junya Kanda; Tatsuo Ichinohe; Yoshiko Atsuta; Yoshihiro Inamoto; Sachiko Seo; Fumihiko Kimura; Masao Ogata
Journal:  Blood Adv       Date:  2019-06-11

5.  Reduced-intensity conditioning is a reasonable alternative for Philadelphia chromosome-positive acute lymphoblastic leukemia among elderly patients who have achieved negative minimal residual disease: a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JSHCT.

Authors:  Yu Akahoshi; Satoshi Nishiwaki; Yasuyuki Arai; Kaito Harada; Yuho Najima; Yoshinobu Kanda; Katsuhiro Shono; Shuichi Ota; Takahiro Fukuda; Naoyuki Uchida; Souichi Shiratori; Masatsugu Tanaka; Junji Tanaka; Yoshiko Atsuta; Shinichi Kako
Journal:  Bone Marrow Transplant       Date:  2020-05-23       Impact factor: 5.483

6.  Comparison of reduced-intensity/toxicity conditioning regimens for umbilical cord blood transplantation for lymphoid malignancies.

Authors:  Nobuhiko Imahashi; Seitaro Terakura; Eisei Kondo; Shinichi Kako; Naoyuki Uchida; Hikaru Kobayashi; Yoshihiro Inamoto; Hitoshi Sakai; Masatsugu Tanaka; Jun Ishikawa; Yasuji Kozai; Ken-Ichi Matsuoka; Takafumi Kimura; Takahiro Fukuda; Yoshiko Atsuta; Junya Kanda
Journal:  Bone Marrow Transplant       Date:  2020-05-21       Impact factor: 5.483

7.  Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups.

Authors:  Yoshihiro Inamoto; Fumihiko Kimura; Junya Kanda; Junichi Sugita; Kazuhiro Ikegame; Hideki Nakasone; Yasuhito Nannya; Naoyuki Uchida; Takahiro Fukuda; Kosuke Yoshioka; Yukiyasu Ozawa; Ichiro Kawano; Yoshiko Atsuta; Koji Kato; Tatsuo Ichinohe; Masami Inoue; Takanori Teshima
Journal:  Haematologica       Date:  2016-08-04       Impact factor: 9.941

8.  Single cord blood transplantation for acute myeloid leukemia patients aged 60 years or older: a retrospective study in Japan.

Authors:  Masamichi Isobe; Takaaki Konuma; Masayoshi Masuko; Naoyuki Uchida; Shigesaburo Miyakoshi; Yasuhiro Sugio; Shuro Yoshida; Masatsugu Tanaka; Yoshiko Matsuhashi; Norimichi Hattori; Makoto Onizuka; Nobuyuki Aotsuka; Yasushi Kouzai; Atsushi Wake; Takafumi Kimura; Tatsuo Ichinohe; Yoshiko Atsuta; Masamitsu Yanada
Journal:  Ann Hematol       Date:  2021-02-23       Impact factor: 3.673

9.  Effect of methotrexate dose in graft-versus-host disease prophylaxis after single-unit cord blood transplantation in adult acute myeloid leukemia.

Authors:  Seitaro Terakura; Yachiyo Kuwatsuka; Junichi Sugita; Satoshi Takahashi; Yukiyasu Ozawa; Kazutaka Ozeki; Satoshi Yoshioka; Hirohisa Nakamae; Toshiro Kawakita; Masashi Sawa; Satoshi Morishige; Yuho Najima; Yuna Katsuoka; Emiko Sakaida; Yasuji Kouzai; Takafumi Kimura; Tatsuo Ichinohe; Takahiro Fukuda; Yoshiko Atsuta; Makoto Murata; Takanori Teshima
Journal:  Int J Hematol       Date:  2021-02-21       Impact factor: 2.490

Review 10.  Hematopoietic stem cell transplantation for acute myeloid leukemia.

Authors:  Akiyoshi Takami
Journal:  Int J Hematol       Date:  2018-01-27       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.